ARCHIVES

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

Porter Novelli Gets $7.4M Contract For 5 A Day Program

October 4, 2002

ASCO Names Stratetic Planning Committee

September 23, 1988

Yates Named DRCCA AD To Head Centers, CCOP, Organ Sites: CCOP Workshops Listed

February 26, 1982

Small Businesses Receive $18 Million From NCI Through SBIR Program

July 31, 1992

NCI To Fund Partnerships Between Cancer Centers and Minority Institutions

November 12, 1999